Divi's Labs very interesting buy: Deepak Mohoni

For the last 3-4 months, Divi's Labs has become an outperformer. It is doing well if not better than most pharmas and it is good steady riser.

In a chat with ET Now, Deepak Mohoni, Director, trendwatchindia.com, shares his stock ideas.

How do Divi's Labs, Excel Crop and Navneet Publications look on the charts?

Divi's Labs has been indeed looking very interesting. Even I have got it as a buy recommendation today. It did not have particularly good two or three years. It has underperformed the market. It underperformed most of its peers. That was not so good but for the last 3-4 months, it has become an outperformer. It is doing well if not better than most pharmas and it is good steady riser.

Excel Crop is perhaps not that strong. It had been very good till about 6-7 months ago. It is still stuttering slightly. So of these three, I would really go with a Divi's.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Divi's Labs very interesting buy: Deepak Mohoni
Text Size:AAA
Success
This article has been saved

*

+